[非hiv患者感染新型冠状病毒感染后的肺囊虫肺炎]。

IF 0.4 4区医学 Q4 INFECTIOUS DISEASES

Revista Chilena De Infectologia Pub Date : 2022-06-01 DOI:10.4067/s0716-10182022000200357

María Amparo-Vicente, Elena Morte

{"title":"[非hiv患者感染新型冠状病毒感染后的肺囊虫肺炎]。","authors":"María Amparo-Vicente, Elena Morte","doi":"10.4067/s0716-10182022000200357","DOIUrl":null,"url":null,"abstract":"Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.","PeriodicalId":21190,"journal":{"name":"Revista Chilena De Infectologia","volume":"39 3","pages":"357-360"},"PeriodicalIF":0.4000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"[Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].\",\"authors\":\"María Amparo-Vicente, Elena Morte\",\"doi\":\"10.4067/s0716-10182022000200357\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.\",\"PeriodicalId\":21190,\"journal\":{\"name\":\"Revista Chilena De Infectologia\",\"volume\":\"39 3\",\"pages\":\"357-360\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Chilena De Infectologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4067/s0716-10182022000200357\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Chilena De Infectologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4067/s0716-10182022000200357","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 1

摘要

由SARS-CoV-2引起的严重呼吸道感染患者感染耶氏肺囊虫是我们今天必须考虑的情况。皮质疗法和其他危险因素使其易感。这是一个诊断挑战，治疗后，预后良好。我们报告一例因SARS-CoV-2感染而患严重肺炎的男性患者，他接受了皮质类固醇治疗，后来因P. jroveci感染而患肺炎。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].

Infection by Pneumocystis jirovecii in patients with severe respiratory infection caused by SARS-CoV-2 is a situation that we must take into account today. Corticotherapy along with other risk factors predisposes to it. It is a diagnostic challenge and, after treatment, the prognosis is favorable. We report the case of a male with severe pneumonia due to SARS-CoV-2 who received corticosteroid treatment, later developing pneumonia due to P. jiroveci.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista Chilena De Infectologia 医学-传染病学

CiteScore

0.90

自引率

20.00%

发文量

审稿时长

4-8 weeks

期刊介绍： La Revista Chilena de Infectología publica artículos en español sobre Infectología latinoamericana. Los propósitos de nuestra revista son: Difundir la experiencia nacional y latinoamericana en la especialidad Divulgar la doctrina de la Sociedad Chilena de Infectología (SOCHINF) sobre el adecuado uso de los recursos diagnósticos, terapéuticos y preventivos de infecciones. Las temáticas que cubre la revista son: Antimicrobianos Epidemiología de Infecciones Infecciones de la Comunidad o Asociadas a la Atención de Salud Infecciones en Hospederos Inmunocomprometidos Microbiología Parasitología Patogénesis VIH Vacunas.